SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-19-020480
Filing Date
2019-04-09
Accepted
2019-04-09 16:21:33
Documents
5
Effectiveness Date
2019-04-09

Document Format Files

Seq Description Document Type Size
1 DEFA14A a19-2683_3defa14a.htm DEFA14A 31998
2 GRAPHIC g26833bci001.gif GRAPHIC 64297
3 GRAPHIC g26833bci002.gif GRAPHIC 100722
4 GRAPHIC g26833bci003.gif GRAPHIC 18479
5 GRAPHIC g26833bci004.gif GRAPHIC 4165
  Complete submission text file 0001104659-19-020480.txt   291753
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-29889 | Film No.: 19739706
SIC: 2834 Pharmaceutical Preparations